Moderna's 2024 Achievements and Strategic Plans for Growth

N/A, Wednesday, 8 January 2025.
Moderna’s 2024 shareholder letter highlights its major advances, including mRESVIA’s approval, positive Phase 3 results, cost reductions, and collaboration with OpenAI to enhance operational efficiency.